Biogen Idec (NASDAQ:BIIB)

Handshake

Anavex Soars on Biogen Agreement

Shares of Anavex Life Sciences Corp. (NASDAQ: AVXL) soared on Wednesday following a material transfer agreement with Biogen Inc. (NASDAQ: BIIB). As for the terms of this agreement, Biogen will ...
Read Full Story »
biotech word cloud

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the most recent settlement date, September 15. Generally speaking, companies within the biotech industry are considered a riskier group of stocks, with big ...
Read Full Story »
biotech word cloud

Short Sellers Run for Cover From Major Biotechs

Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big potential downside. In fact, a cure or incredible new breakthrough in cancer ...
Read Full Story »
bull and bear

Top Analyst Upgrades and Downgrades: Biogen, Broadcom, Devon Energy, Gilead, Mondelez, Urban Outfitters and More

Stocks were indicated marginally higher after the long weekend. With the Dow and S&P 500 being so close to all-time highs, investors have proven over and over that they will ...
Read Full Story »
biotech word cloud

Short Sellers Increase Bets in Major Biotechs

The short interest data are out for the August 15 settlement date. Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big ...
Read Full Story »
automatic inspection machine

Why Jefferies Sees 3 Big Biotechs Having Key Upside Catalysts Coming

After a year of being beaten down by legions of sellers, the biotech segment of the health care sector is finally starting to make a move back for investors, and the ...
Read Full Story »
automatic inspection machine

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the July 29 settlement date. Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big ...
Read Full Story »
money

Merrill Lynch Says the Time to Put Money Into Biotech Is Now

The Nasdaq Biotechnology Index has underperformed the broader market for some time. This year the index is still down about 13%, versus the 6% rise for the S&P 500. We ...
Read Full Story »
analysis

Top Analyst Upgrades and Downgrades: Biogen, Discovery Communications, Mosaic, Plains All American, Phillips 66, Rubicon Project and More

The stock market has pulled back from recent highs after several days of selling pressure. Shares were indicated lower by almost 0.2% for the Dow and S&P 500 on Wednesday ...
Read Full Story »
buy now

RBC Says Buy Big Biotechs Now for Possible Big 2016 Gains

We have talked about it for months here at 24/7 Wall St., and now many on Wall Street are talking about it as well. The selling in biotech, much of ...
Read Full Story »
baby boy's feet

How Biogen and Ionis Won Big (and Can Win More) From Late Stage Trial

Shares of Biogen Inc. (NASDAQ: BIIB) and, especially, Ionis Pharmaceuticals Inc. (NASDAQ: IONS) made handy gains early Monday morning following favorable interim results from a late-stage trial. The companies announced that nusinersen, ...
Read Full Story »
biotech word cloud

Major Biotechs See Increased Short Interest Bets

The short interest data are out for the July 15 settlement date. Companies within the biotech industry are considered a riskier group of stocks, with big potential upside and big ...
Read Full Story »
biotech word cloud

Short Sellers Become More Selective on Major Biotechs

The short interest data are out for the June 30 settlement date. Biotech companies are considered a riskier group of stocks, with big potential upside and big potential downside. In ...
Read Full Story »
automatic inspection machine

5 Top Biotechs Where Future Multi-Billion Dollar Drug Pipelines are Valued Almost at Zero

Sometimes market volatility and outside shocks create a rift between market prices and real value. That may currently be the case in the largest stocks in the biotech sector within health ...
Read Full Story »
biotech word cloud

Short Sellers Run for Cover From Major Biotechs

The short interest data are out for the June 15 settlement date. Biotech companies are considered a riskier group of stocks, with big potential upside and big potential downside. After ...
Read Full Story »